ONWARD Medical Secures Over EUR 50 Million Amid Strong Investor Interest

ONWARD Medical has successfully raised over EUR 50 million, reflecting significant investor interest in its innovative solutions for addressing Spinal cord injury rehabilitation.

• The privately held company ONWARD Medical secured over EUR 50 million in funding, highlighting strong demand from existing investors and potentially expanding its operational capacity.
• The funding round is particularly crucial for ONWARD Medical as it focuses on developing therapies for spinal cord injury, addressing a significant medical need.
• This investment follows ONWARDs partnership with Ottobock, indicating a strategic alliance to enhance its offerings in the equity (finance) space for medical technology.